HomeInsightsStock Comparison

Syngene International Ltd vs Vimta Labs Ltd Stock Comparison

Syngene International Ltd vs Vimta Labs Ltd Stock Comparison

Last Updated on: Jun 23, 2025

Key Highlights

  • The Latest Trading Price of Syngene International Ltd is ₹ 631.5 as of 23 Jun 09:53.
  • The P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 55.3 on March 2024 . This represents a CAGR of 18.67% over 5 yearsThe P/E Ratio of Vimta Labs Ltd changed from 19.1 on March 2020 to 24 on March 2024 . This represents a CAGR of 4.67% over 5 years.
  • The Market Cap of Syngene International Ltd changed from ₹ 9662 crore on March 2020 to ₹ 28209 crore on March 2024 . This represents a CAGR of 23.90% over 5 yearsThe Market Cap of Vimta Labs Ltd changed from ₹ 130.94 crore on March 2020 to ₹ 985.7 crore on March 2024 . This represents a CAGR of 49.74% over 5 years.
  • The revenue of Syngene International Ltd for the Mar '25 is ₹ 1036 crore as compare to the Dec '24 revenue of ₹ 962 crore. This represent the growth of 7.79% The revenue of Vimta Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 95.13 crore. This represent the decline of -100%.
  • The ebitda of Syngene International Ltd for the Mar '25 is ₹ 362.5 crore as compare to the Dec '24 ebitda of ₹ 301.9 crore. This represent the growth of 20.07% The ebitda of Vimta Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 38.29 crore. This represent the decline of -100%.
  • The net profit of Syngene International Ltd changed from ₹ 93.4 crore to ₹ 183.3 crore over 8 quarters. This represents a CAGR of 40.09% The net profit of Vimta Labs Ltd changed from ₹ 12.2 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Vimta Labs Ltd changed from 20.79 % on March 2021 to 6.61 % on March 2025 . This represents a CAGR of -20.48% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
  • The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

About Vimta Labs Ltd

  • Vimta Labs Ltd., established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries.
  • Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products.

Syngene International Ltd News Hub

News

Syngene's Bengaluru-based facility gets 'NAi' status from US FDA

The inspection concluded successfully, with the facility found to be in compliance with th...

Read more

14 Jun 2025 14:28

News

Syngene International to conduct AGM

Syngene International announced that the 32nd Annual General Meeting(AGM) of the company w...

Read more

24 Apr 2025 11:30

News

Board of Syngene International recommends final dividend

Syngene International announced that the Board of Directors of the Company at its meeting ...

Read more

24 Apr 2025 10:43

News

Volumes spurt at Syngene International Ltd counter

Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceutic...

Read more

24 Apr 2025 14:30

News

Syngene International Ltd leads losers in 'A' group

Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other...

Read more

24 Apr 2025 15:00

News

Syngene slides on tepid results and toned-down forecast

On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 c...

Read more

24 Apr 2025 16:22

Vimta Labs Ltd News Hub

News

Vimta Labs allots Equity Shares

Vimta Labs has approved the allotted 2,22,52,784 equity shares of Rs. 2/- each as fully-pa...

Read more

16 Jun 2025 10:39

News

Vimta Labs cancels board meeting

Vimta Labs has cancelled the board meeting which was scheduled to be held on 14 June 2025....

Read more

14 Jun 2025 09:55

News

Vimta Labs to conduct board meeting

Vimta Labs will hold a meeting of the Board of Directors of the Company on 14 June 2025. P...

Read more

07 Jun 2025 10:22

News

Vimta Labs allots 18,272 equity shares under ESOP

Vimta Labs has allotted 18,272 equity shares under ESOP on 23 May 2025. The paid-up share ...

Read more

23 May 2025 16:18

News

Vimta Labs to hold AGM

Vimta Labs announced that the 35th Annual General Meeting(AGM) of the company will be held...

Read more

17 May 2025 12:59

News

Vimta Labs rises after strong Q4 performance; board OKs 1:1 bonus share issue

EBITDA improved by 31.9% to Rs 34.68 crore in Q4 FY25 from Rs 26.30 crore in Q4 FY24. EBIT...

Read more

29 Apr 2025 12:49

SWOT Analysis Of Syngene International Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Vimta Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Syngene International Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vimta Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Syngene International Ltd and Vimta Labs Ltd

Which company has a larger market capitalization, Syngene International Ltd or Vimta Labs Ltd?

Market cap of Syngene International Ltd is 25,463 Cr while Market cap of Vimta Labs Ltd is 2,120 Cr

What are the key factors driving the stock performance of Syngene International Ltd and Vimta Labs Ltd?

The stock performance of Syngene International Ltd and Vimta Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Syngene International Ltd and Vimta Labs Ltd?

As of June 23, 2025, the Syngene International Ltd stock price is INR ₹631.95. On the other hand, Vimta Labs Ltd stock price is INR ₹476.4.

How do dividend payouts of Syngene International Ltd and Vimta Labs Ltd compare?

To compare the dividend payouts of Syngene International Ltd and Vimta Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions